Literature DB >> 25254994

Putting it all together: managing pain in autologous and implant-based breast reconstruction.

Anthony J Wilson1, Michael N Mirzabeigi, Joseph M Serletti.   

Abstract

BACKGROUND: Appropriate pain management in breast reconstruction improves outcomes and patient satisfaction. The purpose of this study is to review the current methodology and paradigms in pain management following breast reconstruction.
METHODS: A review of the scientific literature was performed. The protocols used at our institution were further examined and contrasted in the context of this published literature.
RESULTS: Pain following breast reconstruction is multifactorial and patient specific. Pain can originate from the mastectomy alone, from the donor site, or from tissue expansion. Counseling a patient is of upmost importance. The armamentarium to address pain includes narcotic analgesics, nonnarcotic analgesics, local anesthesia, and other nontraditional regimens. Each of these methods has an evidence-based efficacy and patient selection factors for application.
CONCLUSIONS: The data contained herein provide a review of perioperative pain management following autologous and implant-based breast reconstruction.

Entities:  

Year:  2014        PMID: 25254994     DOI: 10.1097/PRS.0000000000000676

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  2 in total

1.  Transversus Abdominis Plane Blocks with Single-Dose Liposomal Bupivacaine in Conjunction with a Nonnarcotic Pain Regimen Help Reduce Length of Stay following Abdominally Based Microsurgical Breast Reconstruction.

Authors:  Eric M Jablonka; Andreas M Lamelas; Julie N Kim; Bianca Molina; Nathan Molina; Michelle Okwali; William Samson; Mark R Sultan; Joseph H Dayan; Mark L Smith
Journal:  Plast Reconstr Surg       Date:  2017-08       Impact factor: 5.169

2.  Pain and Anxiety Levels of Patients Undergoing Tissue Expansion After Mastectomies: A Case Series Study.

Authors:  Nicole K Le; Carla García-Molina; Ambuj Kumar; Lisa Griffin; Deniz Dayicioglu
Journal:  Cancer Control       Date:  2017 Oct-Dec       Impact factor: 3.302

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.